Update on chronic progressive external ophthalmoplegia

Strabismus

Volumn 13, Issue 3, 2005, Pages 133-142

  Bau, Viktoria ^a   Zierz, Stephan ^b  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

Author keywords

Chronic progressive external ophthalmoplegia; Genetic disorders; Kearns sayre syndrome; Mitochondrial DNA; Mitochondrial encephalomyopathy; Myogenic ptosis

Indexed keywords

MITOCHONDRIAL DNA; MITOCHONDRIAL ENZYME; UBIQUINONE;

CENTRAL NERVOUS SYSTEM; CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; ENDOCRINE SYSTEM; GENE DELETION; GENETIC DISORDER; HEART; HETEROPLASMY; HISTOPATHOLOGY; HUMAN; INNER EAR; LACTATE BLOOD LEVEL; MITOCHONDRIAL ENCEPHALOMYOPATHY; MUSCLE; MUSCLE BIOPSY; PERIPHERAL NERVOUS SYSTEM; POINT MUTATION; PRIORITY JOURNAL; PTOSIS; RESPIRATORY CHAIN; RETINA; REVIEW; SINUS NODE; STRABISMUS; STRABISMUS SURGERY;

HUMANS; MITOCHONDRIA; OPHTHALMOPLEGIA, CHRONIC PROGRESSIVE EXTERNAL; RETINA;

EID: 31544479265     PISSN: 09273972     EISSN: 17445132     Source Type: Journal    
DOI: 10.1080/09273970500216432     Document Type: Review

References (28)

1. Chen RS, Huang CC, Lee CC, et al. Overlapping syndrome of MERRF and MELAS: molecular and neuroradiological studies. Acta Neurol Scand. 1993;87:494-498.
2. Deschauer M. Mitochondriale Enzephalomyopathien. Psychoneurology. 2003;29:108-112.
3. Deschauer M, Müller T, Dreha S, Zierz S. Familiäre mitochondriale chronisch progressive externe Ophthalmoplegie. Nervenarzt. 2001;72:122-129.
4. Deschauer M, Zierz S. Defekte der intergenomischen Kommunikation: Mutationen der Kern-DNA und multiple Deletionen der mitochondrialen DNA bei chronisch progressiver externer Ophthalmoplegie. Akt Neurol. 2003;30:103-106.
5. DiMauro S, Bonilla E, De Vivo DC. Does the patient have a mitochondrial encephalomyopathy? J Child Neurol. 1999;14:23-35.
6. DiMauro S, Bonilla E, Lombes A, et al. Mitochondrial encephalomyopathies. Neurol Clin. 1990;8:483-506.
7. DiMauro S, Moraes CT. Mitochondrial encephalomyopathies. Arch Neurol. 1993;50:1197-1208.
8. Drachman DA. Ophthalmoplegia plus. The neurodegenerative disorders associated with progressive external ophthalmoplegia. Arch Neurol. 1968;18(6):654-674.
9. Gellerich FN, Deschauer M, Chen Y, et al. Mitochondrial respiratory rates and activities of respiratory chain complexes correlate linearly with heteroplasmy of deleted mtDNA without threshold and independently of deletion size. Biochim Biophys Acta. 2002;1556:41-52.
10. (3243)mutation. Brain. 1995;118:721-734.
11. Hirano M. MELAS: an original case and clinical criteria for diagnosis. Neuromusc Disord. 1992;2:125-135.
12. Holt IJ, Harding AE, Cooper JM, et al. Mitochondrial myopathies: clinical and biochemical features of 30 patients with major deletions of muscle mitochondrial DNA. Ann Neurol. 1989;26:699-708.
13. Holt IJ, Harding AE, Morgan-Hughes JA. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature. 1988;331:717-719.
14. Jackson MJ, Schaefer JA, Johnson MA, et al. Presentation and clinical investigation of mitochondrial respiratory chain disease. A study of 51 patients. Brain. 1995;118:339-357.
15. Kaukonen J, Juselius JK, Tiranti V, et al. Role of adenine nucleotide translocator 1 in mtDNA maintenance. Science. 2000;289(5480):782-785.
16. Kearns TP, Sayre GP. Retinitis pigmentosa, external ophthalmoplegia and complete heart block: unusual syndrome with histologic study in one of two cases. AMA Arch Ophthalmol. 1958;60:280-289.
17. Laforet P, Lombes A, Eymard B, et al. Chronic progressive external ophthalmoplegia with ragged-red fibers: clinical, morphological and genetic investigations in 43 patients. Neuromusc Disord. 1995;5:399-413.
18. Lou HC, Reske-Nielsen E. Progressive external ophthalmoplegia: evidence for a disorder in pyruvate-lactate metabolism. Arch Neurol. 1976;33:455-456.
19. Moraes CT, Ciacci F, Silvestri G. Atypical clinical presentations associated with the MELAS Mutation at position 3243 of human mitochondrial DNA. Neuromusc Disord. 1993;3:43-50.
20. Moraes CT, DiMauro S, Zeviani M. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N Engl J Med. 1989;320:1293-1299.
21. Olson W, Engel WK, Walsh GO, Einaugler R. Oculocraniosomatic neuromuscular disease with "ragged-red" fibers. Arch Neurol. 1972;26:193-211.
22. Rowland LP. Molecular genetics, pseudogenetics and clinical neurology. Neurology. 1983;33:1179-1195.
23. Schon EA, Hirano M, DiMauro S. Mitochondrial encephalomyopathies: clinical and molecular analysis. J Bioenerg Biomembr. 1994;26(3):291-299.
24. Shapira Y, Harel S, Russell A. Mitochondrial encephalomyopathies: a group of neuromuscular disorders with defects in oxidative metabolism. Isr J Med Sci. 1977;13(2):161-164.
25. Von Graefe A. Verhandlungen ärztlicher Gesellschaften. Sitzung vom 19. Februar 1868 der Berliner medicinischen Gesellschaft. Berl Klin Wochenschr. 1868;5:126-127.
26. Zeviani M, Servidei S, Gellera C, et al. An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region. Nature. 1989;339(6222):309-311.
27. Zierz S, Von Wersebe O, Gerbitz K, Jerusalem F. Ophthalmoplegia-plus: klinische Variabilität, biochemische Defekte der mitochondrialen Atmungskette und Deletionen des mitochondrialen Genoms. Nervenarzt. 1990;61:332-339.
28. Zintz R, Villiger W. Electron microscopic findings in 3 cases of chronic progressive ocular muscular dystrophy. Ophthalmologica. 1967;153:439-459.